EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Neurodevelopmental Vulnerability in Alzheimer's Disease and Frontotemporal Dementia

Perrine Laury Marie Siguier iD, Mélanie Planton, Bérengère Pages, Fleur Gérard, Marie Rafiq, Marie Wolfrum, Ombeline Archambault, Anise Damour, Valentine Guidolin, Pauline Pefferkorn, Lola Danet, Laurine Virchien and 7 more

European Journal of Neurology · 2025-08 · 32 (8)

DOI: 10.1111/ene.70322 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2025-08-04. Written by Perrine Laury Marie Siguier and 18 co-authors. Institution: ToNIC, Toulouse NeuroImaging Center, UMR 1214, Université de Toulouse, INSERM, Paul Sabatier University (UT3), Pavillon BAUDOT, TOULOUSE Cedex 3, Fra…. Major MEDLINE topics: Alzheimer Disease, Frontotemporal Dementia, Neurodevelopmental Disorders. Cited 5 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Agence Nationale de la Recherche.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Neurodevelopmental disorders (NDDs) may influence the course of Alzheimer's disease (AD) and frontotemporal dementia (FTD). However, prior studies have focused on specific pairs of NDDs and variants of AD/FTD. Adopting a dimensional approach to NDDs and considering the heterogeneity of AD/FTD, we investigated the association between a neurodevelopmental vulnerability (DV) and the clinical presentation and age at onset of AD/FTD.

Methods

We prospectively and consecutively recruited 84 AD/FTD participants and 41 matched controls. AD/FTD participants were classified into typical (amnestic AD, behavioral FTD) and atypical (primary progressive aphasia, frontal and posterior variants of AD, right temporal variant of FTD, amnestic FTD) presentations. Participants underwent a neuropsychological assessment and answered a novel questionnaire on NDDs symptoms. Using k‐means clustering based on the questionnaire, participants were assigned to a DV+ (with neurodevelopmental vulnerability) or a DV− (without) cluster. This data‐driven approach enabled an unbiased classification of individuals with a DV, beyond traditional diagnostic labels.

Results

DV frequencies did not differ between the AD/FTD (18%) and control (15%) χ 2 = 0.205; p = 0.651); and between typical (21%) and atypical (11%) subgroups (Fisher's test, p = 0.184). However, in DV+ patients, symptom onset occurred 8.0 years earlier than in DV− patients (95% CI [−14, −3.0]; p = 0.005), with a median onset age of 58 years (IQR: 15).

Conclusions

A DV could favor early‐onset AD/FTD, but may not affect susceptibility to typical and atypical variants of AD/FTD. The underlying neurophysiological processes involved require future investigation, with implications for precision medicine and individualized treatment strategies. Study Registration Numbers RnIPH 2023‐71 and Research Ethics Committee file No. 2023_765.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseFrontotemporal DementiaNeurodevelopmental DisordersHumansFemaleMaleAgedMiddle AgedProspective StudiesAge of OnsetNeuropsychological Tests

Author keywords

dimensional approachearly‐onset dementialifespan approachneurocognitive disordersneurodevelopmental disorders

Authors and institutions

  • ToNIC, Toulouse NeuroImaging Center, UMR 1214, Université de Toulouse, INSERM, Paul Sabatier University (UT3), Pavillon BAUDOT, TOULOUSE Cedex 3, France.
  • Laboratoire de Neuropsycholinguistique, EA4156, Université de Toulouse, Jean Jaurès University (UT2), Toulouse Cedex 9, France.
  • Department of Neurology, Neuroscience Centre, Toulouse-Purpan University Hospital, Toulouse Cedex 9, France.
  • GREDEVad Commission (Groupe de réflexion sur l'évaluation des troubles neurodéveloppementaux de l'adulte) of the GRECO (Groupe de réflexion sur l'évaluation cognitive), France.
  • Université Marie et Louis Pasteur, INSERM, UMR 1322 LINC, Besançon, France.
  • Centre Mémoire Ressources et Recherche (CMRR), Centre neurodéveloppemental Adulte «Hors Normes», Service de Neurologie, CHRU Besançon, Besançon, France.

ORCID profiles: Perrine Laury Marie Siguier

Funding

  • Agence Nationale de la Recherche

Cite

APA

Siguier, P. L. M., Planton, M., Pages, B., Gérard, F., Rafiq, M., Wolfrum, M., Archambault, O., Damour, A., Guidolin, V., Pefferkorn, P., Danet, L., Virchien, L., Magnin, E., Richard-Mornas, A., Sauvée, M., Thomas-Antérion, C., Mouton, S., Jucla, M., & Pariente, J. (2025). Neurodevelopmental Vulnerability in Alzheimer's Disease and Frontotemporal Dementia. European Journal of Neurology, 32(8). https://doi.org/10.1111/ene.70322

Vancouver

Siguier PLM, Planton M, Pages B, Gérard F, Rafiq M, Wolfrum M, et al. Neurodevelopmental Vulnerability in Alzheimer's Disease and Frontotemporal Dementia. European Journal of Neurology. 2025;32(8). doi:10.1111/ene.70322

BibTeX
@article{Siguier2025,
  author = {Siguier, Perrine Laury Marie and Planton, Mélanie and Pages, Bérengère and Gérard, Fleur and Rafiq, Marie and Wolfrum, Marie and Archambault, Ombeline and Damour, Anise and Guidolin, Valentine and Pefferkorn, Pauline and Danet, Lola and Virchien, Laurine and Magnin, Eloi and Richard-Mornas, Aurélie and Sauvée, Mathilde and Thomas-Antérion, Catherine and Mouton, Servane and Jucla, Mélanie and Pariente, Jérémie},
  title = {Neurodevelopmental Vulnerability in Alzheimer's Disease and Frontotemporal Dementia},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {8},
  doi = {10.1111/ene.70322}
}
Start for free →